Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026)
Becton Dickinson's (BDX) quarterly Cash from Investing Activities came in at -$139.0 million in Q1 2026, down 4.51% year-on-year from -$145.6 million in Q1 2025, and up 24.04% on a QoQ basis from -$183.0 million in Q4 2025.
Becton Dickinson (BDX) Cash from Investing Activities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Cash from Investing Activities data on file, last reported at -$139.0 million in Q1 2026.
- On a quarterly basis, Cash from Investing Activities fell 4.51% year-over-year to -$139.0 million in Q1 2026; TTM through Mar 2026 was -$1.2 billion, a 70.85% increase from a year earlier, with the FY2025 full-year figure at -$818.0 million, up 85.17% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$139.0 million, up from -$183.0 million in the prior quarter.
- Over the last five years, Cash from Investing Activities for BDX reached as high as $204.0 million in Q4 2024 and fell as low as -$3.9 billion in Q3 2024.
- Historically, Cash from Investing Activities has averaged -$582.8 million across 5 years, with a median of -$288.0 million in 2024.
- On a YoY basis, Cash from Investing Activities climbed as much as 187.55% in 2024 and fell as far as 2973.72% in 2024.
- Year by year, Cash from Investing Activities stood at -$291.0 million in 2022, then gained by 19.93% to -$233.0 million in 2023, then soared by 187.55% to $204.0 million in 2024, then tumbled by 189.71% to -$183.0 million in 2025, then rose by 24.04% to -$139.0 million in 2026.
- Per Business Quant data, the three most recent Cash from Investing Activities figures were -$139.0 million in Q1 2026, -$183.0 million in Q4 2025, and -$494.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -218.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -26.60 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -139.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -96.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -58.03 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -43.20 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -90.00 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -77.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -131.58 Mn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | -133.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -139.00 Mn |
| Mar 31, 2026 | -139.00 Mn |
| Dec 31, 2025 | -183.00 Mn |
| Dec 31, 2025 | -183.00 Mn |
| Sep 30, 2025 | -494.00 Mn |
| Sep 30, 2025 | -494.00 Mn |
| Jun 30, 2025 | -395.00 Mn |
| Jun 30, 2025 | -395.00 Mn |
| Mar 31, 2025 | -133.00 Mn |
| Mar 31, 2025 | -133.00 Mn |
| Dec 31, 2024 | 204.00 Mn |
| Dec 31, 2024 | 204.00 Mn |
| Sep 30, 2024 | -3.94 Bn |
| Sep 30, 2024 | -3.94 Bn |
| Jun 30, 2024 | -288.00 Mn |
| Jun 30, 2024 | -288.00 Mn |
| Mar 31, 2024 | -1.06 Bn |
| Mar 31, 2024 | -1.06 Bn |
| Dec 31, 2023 | -233.00 Mn |
| Dec 31, 2023 | -233.00 Mn |